NASDAQ:ELOS Syneron Medical (ELOS) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free ELOS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$11.00▼$11.0050-Day Range N/A52-Week Range$6.18▼$11.43VolumeN/AAverage Volume562,777 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Syneron Medical alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Syneron Medical Stock (NASDAQ:ELOS)Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.Read More Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! ELOS Stock News HeadlinesMarch 13, 2024 | uk.investing.comApax Global Alpha Ltd (APAX)November 14, 2023 | morningstar.comElos Medtech AB Class B ELOS BApril 25, 2024 | Insider Financial (Ad)Thousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.August 21, 2023 | thestreet.comSyneron Medical Stock Hits New 52-Week Low (ELOS)July 13, 2023 | wsj.comElos Medtech AB Series BJune 15, 2023 | thestreet.comSyneron Hires Finance ChiefMay 11, 2023 | marketwatch.comRadio Frequency Beauty Instrument Market 2023 Size, Share and Trends Analysis – Syneron Medical, Lumenis, Valeant Pharmaceutical InternationalJanuary 21, 2023 | cnbc.comAs of July 1, your medical debt may no longer hurt your credit score—here's whyApril 25, 2024 | Insider Financial (Ad)Thousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.January 18, 2022 | thestreet.comSyneron Medical Stock Hits New 52-Week High (ELOS)January 7, 2022 | thestreet.comSyneron Medical (ELOS) Stock Spikes Today on Strong Fourth Quarter GuidanceSee More Headlines Receive ELOS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syneron Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/04/2016Today4/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ELOS CUSIPN/A CIK1291361 Websyneron-candela.com Phone+972-7-32442200FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesShimon Eckhouse Ph.D.Chairman of the BoardAmit MeridorChief Executive OfficerBio & Compensation - Hugo GoldmanChief Financial OfficerBio & Compensation - Erik DowellVice President-North AmericaWilliam GriffingChief Executive Officer - Syneron Candela North AmericaShlomo AlkalayChief Operating OfficerLisa A. SoderquistChief Human Resource OfficerBio & Compensation - Robert RuckExecutive Vice President, Asia PacificRobert FielitzVice President and Managing Director of Europe, Middle East and AfricaSarit Soccary Ben-YochananVice President - Business Development & StrategyMore Executives ELOS Stock Analysis - Frequently Asked Questions How were Syneron Medical's earnings last quarter? Syneron Medical Ltd (NASDAQ:ELOS) released its earnings results on Thursday, August, 4th. The medical equipment provider reported $0.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.03. The medical equipment provider earned $75 million during the quarter, compared to the consensus estimate of $75.72 million. Syneron Medical's revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.07 EPS. What other stocks do shareholders of Syneron Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Syneron Medical investors own include Micron Technology (MU), Advanced Micro Devices (AMD), BIOLASE (BIOL), Cisco Systems (CSCO), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Lannett (LCI), Rite Aid (RAD), Ambarella (AMBA) and Citigroup (C). This page (NASDAQ:ELOS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syneron Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
